Cyclooxygenase-2 and synthesis of PGE2 in human bronchial smooth- muscle cells

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 3, 1997, Pages 864-868

  Viganò, Teresa ^b   Habib, Aida ^b   Hernandez, Alicia ^b   Bonazzi, Albino ^b   Boraschi, Daniela ^b   Lebret, Marylin ^b   Cassina, Enrico ^b   Maclouf, Jacques ^b   Sala, Angelo ^b   Folco, Giancarlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; CYCLOOXYGENASE 2; DEXAMETHASONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; PROSTAGLANDIN E2;

ARTICLE; ASTHMA; BRONCHUS MUSCLE; BRONCHUS REACTIVITY; ENZYME SYNTHESIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION;

EID: 14444273437     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.3.9117018     Document Type: Article

References (35)

1. Samuelsson, B., M. E. Goldyne, E. Granstrom, M. Hamberg, S. Hammarstrom, and C. Malmsten. 1978. Prostaglandins and thromboxanes. Annu. Rev. Biochem. 47:997-1003.
2. Vane, J. R. 1971. Inhibition of prostaglandin synthesis as mechanism of action for aspirine-like drugs. Nature 231:232-235.
3. Silveso, G. R., K. J. Ivey, and J. H. Butt. 1979. Incidence of gastric lesions in patients with rheumatic disease in chronic aspirin therapy. Ann. Intern. Med. 91:517-520.
4. Berg, K. J. 1977. Acute effects of acetylsalicylic acid on renal function in normal man. Eur. J. Clin. Pharmacol. 11:117-123.
5. De Witt, D. L., and W. L. Smith. 1988. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc. Natl. Acad. Sci. U.S.A. 85:1212-1216.
6. Maier, J. A., T. Hla, and T. Maciag. 1990. Cyclooxygenase is an immediate early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem. 265:10805-10808.
7. Xie, W., J. G. Chipman, D. L. Robertson, L. Erikson, and D. L. Simmons. 1991. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 88:2692-2696.
8. Sirois, J., and J. S. Richards. 1992. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles. J. Biol. Chem. 267:6382-6388.
9. Habib, A., C. Creminon, Y. Frobert, J. Grassi, P. Pradelles, and J. Maclouf. 1993. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxylterminal region of the cyclooxygenase-2. J. Biol. Chem. 268:23448-23454.
10. Patrignani, P. M. R. Panara, A. Greco, O. Fusco, C. Natoli, S. Iacobelli, F. Cipollone, A. Ganci, C. Creminon, J. Maclouf, and C. Patrono. 1994. Biochemical and pharamcological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J. Pharmacol. Exp. Ther. 271:1705-1712.
11. Viganò, T., A. Toia, M. T. Crivellari, G. Galli, M. Mezzetti, and G. C. Folco. 1988. Prostaglandin synthetase inhibition and formation of lipoxygenase products in immunologically challenged normal human lung parenchyma. Eicosanoids 1:73-77.
12. Mitchell, J. A., P. Akarasereenont, C. Thiemermann, R. J. Flower, and J. R. Vane. 1994. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A. 90:11693-11697.
13. Laviolette, M., J. Chang, and D. S. Newcombe. 1981. Human alveolar macrophages: a lesion in arachidonic acid metabolism in cigarette smokers. Am. Rev. Respir. Dis. 124:397-401.
14. Churchill, L., F. H. Chilton, J. H. Resau, R. Bascom, W. C. Hubbard, and D. Proud. 1989. Cyclo-oxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am. Rev. Respir. Dis. 140:449-459.
15. 2 in patients with systemic mastocytosis. N. Engl. J. Med. 303:1400-1404.
16. Viganò, T., A. Hernandez, A. Corsini, A. Granata, P. Belloni, R. Fumagalli, R. Paoletti, and G. C. Folco. 1995. Mevalonate pathway and isoprenoids regulate human bronchial myocyte proliferation. Eur. J. Pharmacol. (Mol. Pharmacol.) 291:201-203.
17. Laemmli, U. K. 1970. The assembly of the head of bacteriophage T4. Nature 227:680-681.
18. Jones, D. A., D. P. Carlton, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 1993. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 268:9049-9054.
19. Pradelles, P., J. Grassi, and J. Maclouf. 1985. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal. Chem. 57:1170-1173.
20. Isakson, P., K. Seibert, J. Masferrer, D. Salvemini, L. Lee, and P. Needleman. 1995. Discovery of a better aspirin. In B. Samuelsson, P. W. Ramwell, R. Paoletti, G. C. Folco, E. Granstrom, and S. Nicosia, editors. Advances in Prostaglandin, Thromboxane, and Leukotriene Research, Vol. 23. Raven Press, New York. 49-54.
21. Newman, S. P., R. J. Flower, and J. D. Croxtall. 1994. Dexamethasone suppression of 1L-1β-induced cyclooxygenase-2 expression is not mediated by lipocortin-1 in A549 cells. Biochem. Biophys. Res. Commun. 202:931-939.
22. 2 in human fibroblasts. J. Biol. Chem. 267:23451-23454.
23. Boraschi, D., A. Rambaldi, A. Sica, P. Ghiara, F. Colotta, J. M. Wang, M. De-Rossi, C. Zoia, G. Remuzzi, and F. Bussolino. 1991. Endothelial cells express the interleukin-1 receptor type I. Blood 78:1262-1267.
24. Bird, T. A., A. J. H. Gearing, and J. Saklatvala. 1988. Murine interleukin 1 receptor. J. Biol. Chem. 263:12063-12069.
25. Chizzonite, R., T. Truitt, P. L. Kilian, A. S. Stern, P. Nunes, K. P. Parker, K. L. Kaffka, A. O. Chua, K. Lugg, and U. Gubler. 1989. Two high-affinity interleukin 1 receptors represent separate gene products. Proc. Natl. Acad. Sci. U.S.A. 86:8029-8033.
26. Sims, J. E., M. A. Gayle, J. L. Slack, M. R. Alderson, T. A. Bird, J. G. Giri, F. Colotta, F. Re, A. Mantovani, and K. Shanebeck. 1993. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. U.S.A. 90:6155-6159.
27. Bauerle, P. A. 1991. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072:63-80.
28. Stylianou, E., L. A. J. O'Neill, L. Rawlinson, M. R. Edbrooke, P. Woo, and J. Saklatvala. 1992. Interleukin 1 induces NF-κB through its type I but not its type II receptor in lymphocytes. J. Biol. Chem. 267:15836-15841.
29. Re, F., M. Muzio, M. De Rossi, N. Polentarutti, J. G. Giri, A. Mantovani, and F. Colotta. 1994. The type II "receptor" as a decoy target for interleukin I in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J. Exp. Med. 179:739-743.
30. Anderson, W. H., J. J. Krzanowski, J. B. Polson, and A. Szentivanyi. 1980. Prostaglandins as mediators of tachyphylaxis to histamine in canine tracheal smooth muscle. In B. Samuelsson, P. W. Ramwell, and R. Paoletti, editors. Advances in Prostaglandin and Thromboxane Research, Vol. 7. Raven Press, New York. 995-1001.
31. 2 by bovine cultured airway smooth muscle cells and its inhibition by cyclo-oxygenase inhibitors. Br. J. Pharmacol. 111:983-988.
32. 2. J. Pharmacol. Exp. Ther. 178:541-548.
33. 4 excretion in aspirin-sensitive asthma. Am. J. Respir. Crit. Care Med. 153:572-575.
34. Williams, T. J., and M. J. Peck. 1977. Role of prostaglandin-mediated vasodilatation in inflammation. Nature 270:530-532.
35. Raud, J., S. E. Dahlen, A. Sydbom, L. Lindbom, and P. Hedqvist. 1988. Enhancement of acute allergic inflammation by indomethacin is reversed by prostaglandin E2: apparent correlation with in vivo modulation of mediator release. Proc. Natl. Acad. Sci. U.S.A. 85: 2315-2319.